Welcome to Lipidor AB
Lipidor is a drug delivery company that has developed a new proprietary class of topical medication.

Find out more…

INFO: AKVANO technology delivers clear clinical benefits in many indications. More >>

NEWS: Lipidor AB and Cerbios-Pharma SA strengthen partnership. More >>

NEWS: Lipidor reports positive clinical Phase I/II data in psoriasis. More >>

BUSINESS: We are offering a partnering/ licensing opportunity for a novel sprayable treatment against plaque psoriasis. More >>

AKVANOreg technology represents a completely new dosage form that creates a lipid layer on the skin surface for effective topical delivery* of drugs and skin care treatment. AKVANO formulations offer significant advantages over many currently available treatments, delivering benefits in four key areas:
  • Effective drug delivery achieved through highly efficient physicochemical interaction with the skin barrier.
  • Lipid-based approach enables skin barrier reinforcement and many other possibilities for optimizing topical performance.
  • Improved patient experience due to being non-touch, easy to use, quick drying and non-greasy, as well as having a pleasant feeling on the skin.
  • Favorable product development conditions enabling efficient development and manufacturing of both novel and reformulated products.
AKVANO is suitable for healthy, irritated, injured, or diseased skin, as well as mucous membranes. This means we are able to offer many exciting partnering and licensing opportunities across the entire topical pharmaceutical market as well as for non-
pharmaceutical skin care treatment.
*AKVANO is designed for local treatment, not for transdermal (systemic) delivery.